This is in accordance with previous work reporting the SF3B1 mutation is predominantly found in the luminal A subtype of breast cancer, a subgroup known to have a relatively better outcome than other breast cancer patients (Cancer Genome Atlas Network, 2012; Ellis et al., 2012). This evidence concerns the gene SF3B1 and breast carcinoma.